/Companies

Deepull

Founded 2019 · 71 employees on LinkedIn · 5 known investors

Find your way into Deepull

Sign up to see every warm intro you have to Deepull

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Deepull team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Investors · 5

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Deepull do?
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Who are Deepull's investors?
Deepull's investors include Asabys Partners, Alta Life Sciences, Columbus Venture Partners, Kurma Partners, Panakes Partners.